0000899243-21-034732.txt : 20210901 0000899243-21-034732.hdr.sgml : 20210901 20210901163421 ACCESSION NUMBER: 0000899243-21-034732 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210830 FILED AS OF DATE: 20210901 DATE AS OF CHANGE: 20210901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chopas James George CENTRAL INDEX KEY: 0001836430 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 211230429 MAIL ADDRESS: STREET 1: 950 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-30 0 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001836430 Chopas James George C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE WALTHAM MA 02451 0 1 0 0 See Remarks Common Stock 2021-08-30 4 A 0 7600 0.00 A 7600 D Stock Option (right to buy) 65.41 2021-08-30 4 A 0 21750 0.00 A 2031-08-29 Common Stock 21750 21750 D The shares are issuable upon vesting of restricted stock units that each represent a contingent right to receive one share of APLS common stock. The restricted stock units vest as to 25% of the shares underlying the award on the first anniversary of the grant date and as to an additional 25% of the shares underlying the award annually until the fourth anniversary of the grant date, subject to continued service. This option was granted on August 30, 2021 and vests as to 25% of the shares underlying the option on the first anniversary of the grant date and thereafter as to 1/48th of the shares underlying the option monthly until the fourth anniversary of the grant date, subject to continued service. VP, Corporate Controller / Chief Accounting Officer /s/ David Watson, attorney-in-fact for James Chopas 2021-09-01